US20090326571A1 - Skin rejuvination resurfacing device - Google Patents

Skin rejuvination resurfacing device Download PDF

Info

Publication number
US20090326571A1
US20090326571A1 US12/555,914 US55591409A US2009326571A1 US 20090326571 A1 US20090326571 A1 US 20090326571A1 US 55591409 A US55591409 A US 55591409A US 2009326571 A1 US2009326571 A1 US 2009326571A1
Authority
US
United States
Prior art keywords
needle
skin
needles
based device
hand
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/555,914
Inventor
R. Stephen Mulholland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Invasix Ltd
Original Assignee
Spamedica International Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spamedica International Srl filed Critical Spamedica International Srl
Priority to US12/555,914 priority Critical patent/US20090326571A1/en
Assigned to SPAMEDICA INTERNATIONAL SRL reassignment SPAMEDICA INTERNATIONAL SRL ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MULHOLLAND, R. STEPHEN
Priority to US12/573,923 priority patent/US10799285B2/en
Publication of US20090326571A1 publication Critical patent/US20090326571A1/en
Assigned to INVASIX LTD. reassignment INVASIX LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SPAMEDICA INTERNATIONAL SRL
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/20Surgical instruments, devices or methods, e.g. tourniquets for vaccinating or cleaning the skin previous to the vaccination
    • A61B17/205Vaccinating by means of needles or other puncturing devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00743Type of operation; Specification of treatment sites
    • A61B2017/00747Dermatology
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00743Type of operation; Specification of treatment sites
    • A61B2017/00747Dermatology
    • A61B2017/00765Decreasing the barrier function of skin tissue by radiated energy, e.g. using ultrasound, using laser for skin perforation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00743Type of operation; Specification of treatment sites
    • A61B2017/00792Plastic surgery

Definitions

  • the invention relates to a punctile device in the field of aesthetic and reconstructive medicine and cosmetic surgery to enhance the appearance of skin wrinkles, skin texture and scars.
  • the device and the procedure with which the device is used and referred to herein using punctile resurfacing was developed as a safe and effective skin rejuvenation system for the improvement of moderate wrinkles, scars, pores, pigmentation and skin texture.
  • Lasers use specific wavelengths of light that penetrate the skin, bind to specific chromophores and, through a process called selective photothermolysis remove various colors and pigments from the skin. Other lasers with longer wavelengths of light enter the skin, cause nonspecific heating and improve the texture and fine wrinkling of the skin. Intense pulse light systems release many wavelengths of light at once and also improve the color and texture of the skin through selective photothermolysis. RadioFrequency technologies, use electrical current to heat the dermis (undercarpet of the skin) and stimulate some production of collagen and elastin Fibers that firm and tighten the skin.
  • CO 2 and Erbium laser resurfacing, chemical peels, plasma resurfacing and mechanical dermabrasion remove the outer layers of the skin, in a relatively precise fashion and through the natural healing process, new collagen and elastin is produced in the skin, improving wrinkles and texture.
  • Pin point, segmental or fractional injuries to the skin and dermis can be delivered by laser systems such as FraxelTM, which sends small beams of erbium glass laser wavelengths into the dermis or the Medical Roll CITTM, which is a hand held roller with widely spaced needles.
  • FraxelTM which sends small beams of erbium glass laser wavelengths into the dermis
  • Medical Roll CITTM which is a hand held roller with widely spaced needles.
  • RadioFrequency Devices
  • RadioFrequency technologies use electrical current to heat the dermis (undercarpet of the skin) and stimulate some production of collagen and elastin fibers that firm and tighten the skin.
  • the devices are relatively expensive, have only modest skin texture or wrinkle improvements, being more designed for modest skin tightening.
  • Plasma technologies use saline and electrical current to induce a thin burn on the outer surface of the skin, inducing a dermal injury which heals with increase collagen, elastin and dermal ground substance. Although these devices do produce a good improvement in wrinkles, skin tightening and texture, they are expensive pieces of capital equipment and also run the risk of scarring, hyper or hypopigmenation. The recovery from the procedure is characterized by oozing and discharge and patients are not ready for make up for 2 weeks.
  • Carbon Dioxide or Erbium lasers are used to burn off the outer layer of skin inducing a thermal injury in the dermis which heals by remodeling and increased collagen and elastin production.
  • Resurfacing lasers also produce good wrinkle and texture improvements with skin tightening, but are expensive can potentially cause scars and profound hypopigmentaion and ocular injury and blindness to the user and the patient.
  • the recovery from the procedure is characterized by oozing and discharge and patients are not ready for make up for 2 weeks.
  • Is a fractional dermal injury system that functions by emitting beams of erbium glass laser energy that creates multiple small holes in the dermis, alongside uninjured skin.
  • the fractional dermal injury results in the remodeling without the significant recovery.
  • the fraxel laser is expensive, and has modest results at best.
  • PixelatorTM provides for a resulting dermal remodeling that improves fine to moderate wrinkles, pigmentation and obtains skin texture improvement. Because there is no laser or thermal component to the injury, there is very little risk of hypopigmentation or scarring.
  • the present invention is a procedure and apparatus using a foot pedal controlled power source, that sends electrical energy to a reciprocating hand piece, that is, a hand piece that contains the equipment that causes the reciprocating and oscillating action of the device.
  • a reciprocating hand piece that is, a hand piece that contains the equipment that causes the reciprocating and oscillating action of the device.
  • the reciprocating hand piece provides the rapid oscillating, reciprocating back and forth (“in and out”) motion of the needle tips.
  • the tip of the reciprocator device has a screw on tip to which the needle tip attaches.
  • the working tip of the PixelatorTM reciprocator or needle-based device is the needle tip. It is a series of a number of needles in a desired array, typically 12 needles, two rows of 6 needles affixed in a rectangle, to a long stainless steel shaft and it screws onto the tip of the handpiece or headpiece. Other needle arrays are contemplated such as 8 needles up to 16 needles, with different configurations to the needle tips themselves.
  • the needle tip while reciprocating in and out rapidly will have some toggle and to prevent this, a sheath is inserted over the needle tip and a disposable plastic tip protector is inserted inside the sheath.
  • the plastic tip can be pushed in or withdrawn to expose more or less of the needle tip.
  • the plastic tip controls the depth of penetration.
  • the PixelatorTM needle-based device is a skin rejuvenation device that works on the principle of fractional dermal injury, but induced through a high speed, non-thermal, needle based mechanical trauma.
  • Anesthesia The patient is usually anesthetized with local anesthesia.
  • the upper and lower lips, lower eyelids, frown line region and any area of acne scarring can by infiltrated with local anesthesia and treated.
  • Punctile Resurfacing The hand piece and tip is placed over the skin with direct contact of the needle tip with the skin. By depressing the foot pedal, the 40 Hz reciprocating oscillations (“in and out” motions of the needle tip) begin and with each reciprocation the needles penetrate into the dermis, according to the depth that was set on by the adjustment of the plastic tip protector.
  • the PixelatorTM hand piece is then passed in one direction across the whole surface area to be treated. The movements are gentle but fast and move in one direction. Once one pass of the entire treatment area has been completed the hand piece and needle tip are then passed in the opposite direction, about 90 degrees to the first pass. Once this pass is completed a third pass is made 90 degrees to the previous pass.
  • Punctile Resurfacing End Point After about 6-9 criss-crossing passes on the skin, there will be a deep bruised discoloration to the skin and edema. Once the ecchymotic, bruised discoloration and edema has eliminated or greatly reduced the wrinkle, scar or textural abnormality and the color of the dermal bruise is dark blue, the end point of treatment has arrived. Generally an upper lip or lower lid sized zone takes 10 minutes to reach the therapeutic end point.
  • Post-Punctile Resurfacing Care As punctile resurfacing is a fractional injury, there is a microscopic but substantial area of the epidermis that is intact. The intact epidermis affects a very rapid hemostatic effect and re-epithelialization repair. As a consequence, the patients punctile resurfacing area, although bruised in appearance, exhibits minimal oozing and discomfort as the superficial epidermis is re-epithelialize within 24-48 hours. Cleansing with water and a topical emollient, such as PolysporinTM ointment is the only after care.
  • a topical emollient such as PolysporinTM ointment
  • Punctile Resurfacing Results Over the 6-12 weeks post-punctile resurfacing, the bruising and edema resolves in 4-5 days and the patient may wear makeup. By 3-4 months, the mechanical trauma and inflammation that was induced by the fractional needle punctures has induced and post inflammatory reaction resulting in new dermal collagen, elastin and ground substance production. The clinical results are smoother wrinkles, improvement in depressed scars, pores, brown discoloration and enhanced skin texture.
  • PixelatorTM needle-based device that are used and/or beneficial in the novel procedure are the more closely spaced needle configuration for more precise fractional dermal injury, the reciprocating mechanical handpiece for more rapid and predictable treatment of areas, the adjustable tip for more control over the depth of the dermal injury, the hand held, comfortable, light and 110-volt out of the wall power source (although DC current is also contemplated), the disposable needle tip and plastic tip guide, the device headpiece and sheath can be reused, the low cost of operation, the fact that the procedure does not use a laser device, making it safer for the operator and patient, and that there is little risk of scars or hypopigmenation as PixelatorTM needle-based device causes a non-thermal mediated injury.
  • the inventive procedure is a skin rejuvenation resurfacing procedure comprising performing a punctile resurfacing procedure using an oscillating, reciprocating high speed, non-thermal, needle-based device for inducing mechanical trauma to an area of the skin to be treated.
  • a desired number of passes are made over the surface area of the skin to be treated in a criss-crossing pattern until there is a deep bruised discoloration and edema to the area of the skin being treated such that a wrinkle, scar or textural abnormality being treated has been eliminated or greatly reduced.
  • the area of the skin treated is cleansed and a topical emollient is applied.
  • the resultant bruising and edema resolves in 4-5 days such that make-up may be worn on the treated area, and the mechanical trauma and inflammation that was induced by fractional needle punctures and the post inflammatory reaction results in new dermal collagen, elastin and ground substance production thereby resulting in smoother wrinkles, improvement in depressed scars and enhanced skin texture.
  • the patient being treated Prior to starting the resurfacing treatment, the patient being treated is anesthetized with local anesthesia to the area of the skin to be treated.
  • FIG. 1 is a schematic depiction of one example of the major system components used in the inventive procedure
  • FIG. 2A is a cross-sectional view of the needle tip area
  • FIG. 2B is an end view of the needle tip area of FIG. 2A ;
  • FIG. 3 is a depiction of a typical needle, needle tip sheath and needle tip plastic protector
  • FIG. 4A is a depiction of the end of the needle tip area being directed in a path with the needles in a partially retracted position
  • FIG. 4B is a depiction similar to FIG. 4A with the needles in an extended position.
  • FIGS. 1 , 2 A, 2 B, 3 , 4 A and 4 B disclose an example of the major system components used in the inventive procedure. Reference to these components will be made in describing the inventive procedure.
  • the invention is a skin rejuvenation resurfacing procedure and its associated apparatus wherein a punctile resurfacing procedure is performed on a subject patient using an oscillating, reciprocating high speed, non-thermal, needle-based device 12 for inducing mechanical trauma to an area of the skin to be treated.
  • a punctile resurfacing procedure is performed on a subject patient using an oscillating, reciprocating high speed, non-thermal, needle-based device 12 for inducing mechanical trauma to an area of the skin to be treated.
  • the patient being treated Prior to commencing the procedure, the patient being treated is anesthetized with local anesthesia to the area of the skin to be treated.
  • a desired number of passes are made over the surface area of the skin to be treated in a criss-crossing pattern until there is a deep bruised discoloration and edema to the area of the skin being treated such that a wrinkle, scar or textural abnormality being treated has been eliminated or greatly reduced.
  • the skin area to be treated is treated using the needle-based device 12 by passing in a first direction. Then an alternating pass is done in a generally criss-crossing pattern to the first direction and the treatment is repeated in this alternating criss-crossing pattern.
  • the typical desired number of passes made over the area of the skin to be treated in the criss-crossing pattern is six to nine passes in each direction of the criss-crossing pattern.
  • the area of the skin treated is cleansed and a topical emollient, such as PolysporinTM anti-bacterial ointment is applied.
  • a topical emollient such as PolysporinTM anti-bacterial ointment
  • the resultant bruising and edema resolves in 4-5 days such that make-up may be worn on the treated area, and the mechanical trauma and inflammation that was induced by fractional needle punctures and the post inflammatory reaction results in new collagen, elastin and ground substance production thereby resulting in smoother wrinkles, improvement in depressed scars, lessened pigmentation and enhanced skin texture.
  • the needle-based device 12 is a hand-held device and is the power is controlled by a hands-free means.
  • a foot pedal or foot control switch 16 is typically used in the control circuit between a power controller source 14 and the hand-held needle-based device 12 .
  • the power controller source is depicted in FIG. 1 as being powered by an alternating current source but alternatively could be powered by a direct current source.
  • the needle-based device includes needle depth adjustment means for obtaining a desired skin penetration depth of needle tip 12 b of a plurality of needles 12 d for the appropriate treatment of the area of the skin being treated.
  • the plurality of needles 12 d are preferably arranged in an array comprising between eight to sixteen needles.
  • FIG. 2 b depicts an array of 12 needles arranged in a 2 ⁇ 6 configuration.
  • the needle-based device 12 comprises a hand-held portion 12 a housing means for oscillating and reciprocating an elongate needle portion 12 b.
  • the needles 12 d oscillate/reciprocate at about 40 cycles per second to about 100 cycles per second.
  • the elongate needle portion 12 b has at its opposite end, a plurality of needles 12 d configured in a desired array, such as 2 ⁇ 6.
  • a needle sheath 12 c is provided to slide over the needle portion 12 b and attach to the hand piece 12 a.
  • the attachment can be by threaded means or other methods known in the art.
  • Sheath 12 c generally covers the elongate needle portion 12 b and is connected to the hand-hand portion 12 a and ends with the array of the plurality of needles 12 d.
  • the needle sheath 12 c further serves as means for preventing a side to side movement of the elongate needle portion 12 b.
  • a needle tip protector 12 e is attached over the plurality of needles 12 d and is slidably operable over the plurality of needles 12 d for serving as the needle depth adjustment means for obtaining the desired depth of needle penetration of said needle tips to the skin area being treated.
  • the protector is slidably engaged with the end of the sheath 12 c and is pushed into or pulled away from the end of the sheath 12 c so that when the needle tips are extended at the maximum reciprocation distance away from hand piece 12 a, the distance between the tips and the protector edge equates to the maximum penetration depth desired to accomplish the desired treatment.

Abstract

A skin rejuvenation resurfacing apparatus comprising an oscillating, reciprocating high speed, non-thermal, needle-based device for inducing mechanical trauma to an area of the skin to be treated.

Description

    RELATED APPLICATION
  • This application is a continuation application of nonprovisional application Ser. No. 11/315,841 filed Dec. 22, 2005.
  • FIELD OF THE INVENTION
  • The invention relates to a punctile device in the field of aesthetic and reconstructive medicine and cosmetic surgery to enhance the appearance of skin wrinkles, skin texture and scars.
  • BACKGROUND OF THE INVENTION
  • The device and the procedure with which the device is used and referred to herein using punctile resurfacing was developed as a safe and effective skin rejuvenation system for the improvement of moderate wrinkles, scars, pores, pigmentation and skin texture.
  • In the aesthetic industry there are many procedures using devices that improve the appearance of the skin. These devices can be divided into laser, broad band light, mechanical and radiofrequency systems.
  • Lasers use specific wavelengths of light that penetrate the skin, bind to specific chromophores and, through a process called selective photothermolysis remove various colors and pigments from the skin. Other lasers with longer wavelengths of light enter the skin, cause nonspecific heating and improve the texture and fine wrinkling of the skin. Intense pulse light systems release many wavelengths of light at once and also improve the color and texture of the skin through selective photothermolysis. RadioFrequency technologies, use electrical current to heat the dermis (undercarpet of the skin) and stimulate some production of collagen and elastin Fibers that firm and tighten the skin. More ablative technology, CO2 and Erbium laser resurfacing, chemical peels, plasma resurfacing and mechanical dermabrasion remove the outer layers of the skin, in a relatively precise fashion and through the natural healing process, new collagen and elastin is produced in the skin, improving wrinkles and texture.
  • Pin point, segmental or fractional injuries to the skin and dermis can be delivered by laser systems such as Fraxel™, which sends small beams of erbium glass laser wavelengths into the dermis or the Medical Roll CIT™, which is a hand held roller with widely spaced needles. The advantage of these segmental, fractional injury and puncturing procedures, is the dermis is stimulated with either a heat or mechanical trauma and the inflammatory response results in dermal remodeling and the production of new collagen, elastin and ground substance and ultimately, skin enhancement and rejuvenation.
  • The development of the device described herein and the punctile remodeling procedure was designed to deploy, through the proven efficacy of the fractional approach to dermal injury, remodeling and rejuvenation with a precision, high speed, mechanical needle puncture system and procedure that would safely and effectively improve the texture and appearance of skin with out the need for laser heating.
  • Industry and Device Comparisons Monochromatic Lasers:
  • These devices use specific wavelengths of light that penetrate the skin, bind to specific chromophores and, through a process called selective photothermolysis, remove various colors and pigments from the skin. The lasers are large, expensive pieces of capital equipment, only attack specific problems or colors in the skin, are prone to laser bums, scars, can cause hyper and/or hypopigmentation and may result in user and patient ocular injuries.
  • Intense Broad Band Light Systems:
  • These systems emit multiple wavelengths of light, and through selective photothermolysis, also improve skin discoloration and, through skin heating, non-specific skin texture improvement. The systems are also larger and expensive, the skin textures and wrinkle improvements are minimal and there is also the risk of skin bums, hypo or hyperpigmentaiton and scars.
  • RadioFrequency Devices:
  • RadioFrequency technologies, use electrical current to heat the dermis (undercarpet of the skin) and stimulate some production of collagen and elastin fibers that firm and tighten the skin. The devices are relatively expensive, have only modest skin texture or wrinkle improvements, being more designed for modest skin tightening. There is also a risk of localized fat necrosis, with permanent dimpling, damage to sensory nerves and scarring.
  • Plasma Technology:
  • Plasma technologies use saline and electrical current to induce a thin burn on the outer surface of the skin, inducing a dermal injury which heals with increase collagen, elastin and dermal ground substance. Although these devices do produce a good improvement in wrinkles, skin tightening and texture, they are expensive pieces of capital equipment and also run the risk of scarring, hyper or hypopigmenation. The recovery from the procedure is characterized by oozing and discharge and patients are not ready for make up for 2 weeks.
  • Laser Resurfacing and Chemical Peel:
  • Carbon Dioxide or Erbium lasers are used to burn off the outer layer of skin inducing a thermal injury in the dermis which heals by remodeling and increased collagen and elastin production. Resurfacing lasers also produce good wrinkle and texture improvements with skin tightening, but are expensive can potentially cause scars and profound hypopigmentaion and ocular injury and blindness to the user and the patient. The recovery from the procedure is characterized by oozing and discharge and patients are not ready for make up for 2 weeks.
  • Fraxel Laser:
  • Is a fractional dermal injury system that functions by emitting beams of erbium glass laser energy that creates multiple small holes in the dermis, alongside uninjured skin. The fractional dermal injury results in the remodeling without the significant recovery. The fraxel laser is expensive, and has modest results at best.
  • Medical Roll CIT:
  • This is also a fractional dermal injury system. It is a hand held roller with needles mounted on the roller. It is passed repeatedly by hand across the skin creating a dermal injury but leaving a large portion of the epidermis intake. There is some bruising and swelling, but very little pain, weeping or oozing. The mechanical injury to the dermis results in some structural collagen and elastic, smoothening out fine winkles. The needles are very long and widely spaced and the patients experience a significant amount of discomfort due to the length of the needle. The hand held nature of the device, make predictable spacing of the segmental injury imprecise.
  • What is needed is a procedure using a Pixelatory™ and Punctile Resurfacing device. The inventor herein has developed a more efficient, fast, predictable and less painful device and procedure than the above described Medical Roll CIT device and its procedure. The present inventive using the inventor's developed Pixelator™ device provides for a resulting dermal remodeling that improves fine to moderate wrinkles, pigmentation and obtains skin texture improvement. Because there is no laser or thermal component to the injury, there is very little risk of hypopigmentation or scarring.
  • SUMMARY OF THE INVENTION
  • The present invention is a procedure and apparatus using a foot pedal controlled power source, that sends electrical energy to a reciprocating hand piece, that is, a hand piece that contains the equipment that causes the reciprocating and oscillating action of the device. The reciprocating hand piece provides the rapid oscillating, reciprocating back and forth (“in and out”) motion of the needle tips. The tip of the reciprocator device has a screw on tip to which the needle tip attaches.
  • The working tip of the Pixelator™ reciprocator or needle-based device is the needle tip. It is a series of a number of needles in a desired array, typically 12 needles, two rows of 6 needles affixed in a rectangle, to a long stainless steel shaft and it screws onto the tip of the handpiece or headpiece. Other needle arrays are contemplated such as 8 needles up to 16 needles, with different configurations to the needle tips themselves.
  • The needle tip while reciprocating in and out rapidly will have some toggle and to prevent this, a sheath is inserted over the needle tip and a disposable plastic tip protector is inserted inside the sheath. The plastic tip can be pushed in or withdrawn to expose more or less of the needle tip. Thus, the plastic tip controls the depth of penetration.
  • The Pixelator™ needle-based device is a skin rejuvenation device that works on the principle of fractional dermal injury, but induced through a high speed, non-thermal, needle based mechanical trauma. Once the Midas headpiece is assembled, the plastic tip protector is advanced in or out of the sheath to set the length of the punctile needles that will be exposed to the skin during the treatment, providing a controllable “depth gauge” for the depth of dermal injury.
  • Anesthesia: The patient is usually anesthetized with local anesthesia. The upper and lower lips, lower eyelids, frown line region and any area of acne scarring can by infiltrated with local anesthesia and treated.
  • Punctile Resurfacing: The hand piece and tip is placed over the skin with direct contact of the needle tip with the skin. By depressing the foot pedal, the 40 Hz reciprocating oscillations (“in and out” motions of the needle tip) begin and with each reciprocation the needles penetrate into the dermis, according to the depth that was set on by the adjustment of the plastic tip protector. The Pixelator™ hand piece is then passed in one direction across the whole surface area to be treated. The movements are gentle but fast and move in one direction. Once one pass of the entire treatment area has been completed the hand piece and needle tip are then passed in the opposite direction, about 90 degrees to the first pass. Once this pass is completed a third pass is made 90 degrees to the previous pass. With this criss-crossing pattern, up 6-9 passes may be made in each treatment zone. With each pass there is a small amount of pin-point bleeding, which stops very quickly, due to the fractional nature of the injury and the presence of bridging epthermal skin segments. Most of the trauma is dermal and ecchymosis (bruising) is induced under the skin. It is the post dermal inflammation that will determine the level of new dermal substrate formation. After each pass, the small amount of blood residual on the surface is wiped off, clotting occurs very quickly and the next pass initiated.
  • Punctile Resurfacing End Point: After about 6-9 criss-crossing passes on the skin, there will be a deep bruised discoloration to the skin and edema. Once the ecchymotic, bruised discoloration and edema has eliminated or greatly reduced the wrinkle, scar or textural abnormality and the color of the dermal bruise is dark blue, the end point of treatment has arrived. Generally an upper lip or lower lid sized zone takes 10 minutes to reach the therapeutic end point.
  • Post-Punctile Resurfacing Care: As punctile resurfacing is a fractional injury, there is a microscopic but substantial area of the epidermis that is intact. The intact epidermis affects a very rapid hemostatic effect and re-epithelialization repair. As a consequence, the patients punctile resurfacing area, although bruised in appearance, exhibits minimal oozing and discomfort as the superficial epidermis is re-epithelialize within 24-48 hours. Cleansing with water and a topical emollient, such as Polysporin™ ointment is the only after care.
  • Punctile Resurfacing Results: Over the 6-12 weeks post-punctile resurfacing, the bruising and edema resolves in 4-5 days and the patient may wear makeup. By 3-4 months, the mechanical trauma and inflammation that was induced by the fractional needle punctures has induced and post inflammatory reaction resulting in new dermal collagen, elastin and ground substance production. The clinical results are smoother wrinkles, improvement in depressed scars, pores, brown discoloration and enhanced skin texture.
  • Features of the Pixelator™ needle-based device that are used and/or beneficial in the novel procedure are the more closely spaced needle configuration for more precise fractional dermal injury, the reciprocating mechanical handpiece for more rapid and predictable treatment of areas, the adjustable tip for more control over the depth of the dermal injury, the hand held, comfortable, light and 110-volt out of the wall power source (although DC current is also contemplated), the disposable needle tip and plastic tip guide, the device headpiece and sheath can be reused, the low cost of operation, the fact that the procedure does not use a laser device, making it safer for the operator and patient, and that there is little risk of scars or hypopigmenation as Pixelator™ needle-based device causes a non-thermal mediated injury.
  • The inventive procedure is a skin rejuvenation resurfacing procedure comprising performing a punctile resurfacing procedure using an oscillating, reciprocating high speed, non-thermal, needle-based device for inducing mechanical trauma to an area of the skin to be treated.
  • A desired number of passes are made over the surface area of the skin to be treated in a criss-crossing pattern until there is a deep bruised discoloration and edema to the area of the skin being treated such that a wrinkle, scar or textural abnormality being treated has been eliminated or greatly reduced.
  • After the procedure is completed using the needle-based device, the area of the skin treated is cleansed and a topical emollient is applied.
  • The resultant bruising and edema resolves in 4-5 days such that make-up may be worn on the treated area, and the mechanical trauma and inflammation that was induced by fractional needle punctures and the post inflammatory reaction results in new dermal collagen, elastin and ground substance production thereby resulting in smoother wrinkles, improvement in depressed scars and enhanced skin texture.
  • Prior to starting the resurfacing treatment, the patient being treated is anesthetized with local anesthesia to the area of the skin to be treated.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • In the accompanying drawings:
  • FIG. 1 is a schematic depiction of one example of the major system components used in the inventive procedure;
  • FIG. 2A is a cross-sectional view of the needle tip area;
  • FIG. 2B is an end view of the needle tip area of FIG. 2A;
  • FIG. 3 is a depiction of a typical needle, needle tip sheath and needle tip plastic protector;
  • FIG. 4A is a depiction of the end of the needle tip area being directed in a path with the needles in a partially retracted position; and
  • FIG. 4B is a depiction similar to FIG. 4A with the needles in an extended position.
  • DETAILED DESCRIPTION OF THE INVENTION
  • Referring now to the drawings, FIGS. 1, 2A, 2B, 3, 4A and 4B disclose an example of the major system components used in the inventive procedure. Reference to these components will be made in describing the inventive procedure.
  • The invention is a skin rejuvenation resurfacing procedure and its associated apparatus wherein a punctile resurfacing procedure is performed on a subject patient using an oscillating, reciprocating high speed, non-thermal, needle-based device 12 for inducing mechanical trauma to an area of the skin to be treated. Prior to commencing the procedure, the patient being treated is anesthetized with local anesthesia to the area of the skin to be treated.
  • A desired number of passes are made over the surface area of the skin to be treated in a criss-crossing pattern until there is a deep bruised discoloration and edema to the area of the skin being treated such that a wrinkle, scar or textural abnormality being treated has been eliminated or greatly reduced.
  • The skin area to be treated is treated using the needle-based device 12 by passing in a first direction. Then an alternating pass is done in a generally criss-crossing pattern to the first direction and the treatment is repeated in this alternating criss-crossing pattern. The typical desired number of passes made over the area of the skin to be treated in the criss-crossing pattern is six to nine passes in each direction of the criss-crossing pattern.
  • After this step is completed, the area of the skin treated is cleansed and a topical emollient, such as Polysporin™ anti-bacterial ointment is applied.
  • The resultant bruising and edema resolves in 4-5 days such that make-up may be worn on the treated area, and the mechanical trauma and inflammation that was induced by fractional needle punctures and the post inflammatory reaction results in new collagen, elastin and ground substance production thereby resulting in smoother wrinkles, improvement in depressed scars, lessened pigmentation and enhanced skin texture.
  • The needle-based device 12 is a hand-held device and is the power is controlled by a hands-free means. For example, a foot pedal or foot control switch 16 is typically used in the control circuit between a power controller source 14 and the hand-held needle-based device 12. The power controller source is depicted in FIG. 1 as being powered by an alternating current source but alternatively could be powered by a direct current source.
  • The needle-based device includes needle depth adjustment means for obtaining a desired skin penetration depth of needle tip 12 b of a plurality of needles 12 d for the appropriate treatment of the area of the skin being treated. The plurality of needles 12 d are preferably arranged in an array comprising between eight to sixteen needles. For example, FIG. 2 b depicts an array of 12 needles arranged in a 2×6 configuration.
  • The needle-based device 12 comprises a hand-held portion 12 a housing means for oscillating and reciprocating an elongate needle portion 12 b. This a commercially available hand piece, also referred to as head piece, which houses the motor and oscillating means (not shown) and to which the elongate needle portion 12 b is connected at one end and in mechanical communication with the means for oscillating and reciprocating said needle portion 12 b. Typically, the needles 12 d oscillate/reciprocate at about 40 cycles per second to about 100 cycles per second.
  • As mentioned above, the elongate needle portion 12 b has at its opposite end, a plurality of needles 12 d configured in a desired array, such as 2×6.
  • A needle sheath 12 c is provided to slide over the needle portion 12 b and attach to the hand piece 12 a. The attachment can be by threaded means or other methods known in the art. Sheath 12 c generally covers the elongate needle portion 12 b and is connected to the hand-hand portion 12 a and ends with the array of the plurality of needles 12 d. The needle sheath 12 c further serves as means for preventing a side to side movement of the elongate needle portion 12 b.
  • A needle tip protector 12 e is attached over the plurality of needles 12 d and is slidably operable over the plurality of needles 12 d for serving as the needle depth adjustment means for obtaining the desired depth of needle penetration of said needle tips to the skin area being treated. Typically, the protector is slidably engaged with the end of the sheath 12 c and is pushed into or pulled away from the end of the sheath 12 c so that when the needle tips are extended at the maximum reciprocation distance away from hand piece 12 a, the distance between the tips and the protector edge equates to the maximum penetration depth desired to accomplish the desired treatment.
  • It should be understood that the preceding is merely a detailed description of one or more embodiments of this invention and that numerous changes to the disclosed embodiments can be made in accordance with the disclosure herein without departing from the spirit and scope of the invention. The preceding description, therefore, is not meant to limit the scope of the invention. Rather, the scope of the invention is to be determined only by the appended claims and their equivalents.

Claims (7)

1. An apparatus for use in a skin rejuvenation resurfacing procedure comprising:
a non-thermal needle base device configured for inducing a mechanical trauma transdermally into the epidermis, dermis and subcutaneous fat;
means for oscillating and reciprocating at a high speed an elongated needle portion of said needle-based device and means for operating said needle based device at about 40 cycles per second to 100 cycles per second to induce a purposeful full skin thickness injury and inflammatory response that leads to collagen, elastic and ground substances to resurface a patient's skin;
the needle-based device including needle depth adjustment means for obtaining a desired transdermal penetration needle tip depth sufficient to penetrate through said epidermis, dermis and into said subcutaneous fat of needle tips of a plurality of needles for the appropriate treatment of the area of the skin being treated; and
the needle-based device further comprising:
a hand-held portion comprising means for oscillating and reciprocating an elongated needle portion,
the elongated needle portion being connected at one end to said hand-held portion and in mechanical communication with said means for oscillating and reciprocating said needle portion,
the elongated needle portion having at its opposite end, the plurality of needles configured in a desired array.
2. The apparatus according to claim 1, wherein the needle-based device is a hand-held, mechanical device and is controllable by hands-free means.
3. The apparatus according to claim 2, wherein the hands-free means for controlling the needle-based device is a foot control switch between a power controller source and the hand-held needle-based device.
4. The apparatus according to claim 1, wherein the plurality of needles are arranged in an array comprising between eight to sixteen needles.
5. The apparatus according to claim 1, wherein the needle-based device further comprises:
a needle sheath generally covering said elongate needle portion and connected to the hand-hand portion and ending near the plurality of needles, said needle sheath further serving as means for preventing a side to side movement of the elongate needle portion; and
a needle tip protector attached over the plurality of needles, said needle tip protector being slidably operable over the plurality of needles for serving as the needle depth adjustment means for obtaining the desired depth of needle penetration of said needle tips to the skin area being treated.
6. The apparatus according to claim 5, wherein the plurality of needles are arranged in an array comprising between eight to sixteen needles.
7. The apparatus according to claim 6, comprising twelve needles.
US12/555,914 2005-12-22 2009-09-09 Skin rejuvination resurfacing device Abandoned US20090326571A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US12/555,914 US20090326571A1 (en) 2005-12-22 2009-09-09 Skin rejuvination resurfacing device
US12/573,923 US10799285B2 (en) 2005-12-22 2009-10-06 Skin rejuvenation resurfacing device and method of use

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/315,841 US7618429B2 (en) 2005-12-22 2005-12-22 Skin rejuvination resurfacing method
US12/555,914 US20090326571A1 (en) 2005-12-22 2009-09-09 Skin rejuvination resurfacing device

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US11/315,841 Continuation US7618429B2 (en) 2005-12-22 2005-12-22 Skin rejuvination resurfacing method

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/315,841 Continuation-In-Part US7618429B2 (en) 2005-12-22 2005-12-22 Skin rejuvination resurfacing method

Publications (1)

Publication Number Publication Date
US20090326571A1 true US20090326571A1 (en) 2009-12-31

Family

ID=38175461

Family Applications (2)

Application Number Title Priority Date Filing Date
US11/315,841 Active 2027-03-10 US7618429B2 (en) 2005-12-22 2005-12-22 Skin rejuvination resurfacing method
US12/555,914 Abandoned US20090326571A1 (en) 2005-12-22 2009-09-09 Skin rejuvination resurfacing device

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US11/315,841 Active 2027-03-10 US7618429B2 (en) 2005-12-22 2005-12-22 Skin rejuvination resurfacing method

Country Status (2)

Country Link
US (2) US7618429B2 (en)
CA (1) CA2568482C (en)

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160331440A1 (en) * 2009-07-27 2016-11-17 Novoxel Ltd. Methods and devices for tissue ablation
US9629991B1 (en) 2016-06-08 2017-04-25 Eclipse Aesthetics, LLC Disposable radio frequency needle cartridges having absorbing containment barriers
US9636491B1 (en) 2016-06-08 2017-05-02 Eclipse Aesthetics, LLC Disposable needle cartridges having absorbing contaminant barriers
US10220195B2 (en) 2016-06-08 2019-03-05 Eclipse Medcorp, Llc Radio frequency needling device for use with disposable needle cartridges
US10702328B2 (en) 2013-12-18 2020-07-07 Novoxel Ltd. Devices and methods for tissue vaporization
US11083515B2 (en) 2013-12-18 2021-08-10 Novoxel Ltd. Methods and devices for thermal tissue vaporization and compression
US11141219B1 (en) 2016-08-16 2021-10-12 BTL Healthcare Technologies, a.s. Self-operating belt
US11185690B2 (en) 2016-05-23 2021-11-30 BTL Healthcare Technologies, a.s. Systems and methods for tissue treatment
US11247039B2 (en) 2016-05-03 2022-02-15 Btl Healthcare Technologies A.S. Device including RF source of energy and vacuum system
US11247063B2 (en) 2019-04-11 2022-02-15 Btl Healthcare Technologies A.S. Methods and devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy
US11253717B2 (en) 2015-10-29 2022-02-22 Btl Healthcare Technologies A.S. Aesthetic method of biological structure treatment by magnetic field
US11253718B2 (en) 2015-07-01 2022-02-22 Btl Healthcare Technologies A.S. High power time varying magnetic field therapy
US11266852B2 (en) 2016-07-01 2022-03-08 Btl Healthcare Technologies A.S. Aesthetic method of biological structure treatment by magnetic field
US11464993B2 (en) 2016-05-03 2022-10-11 Btl Healthcare Technologies A.S. Device including RF source of energy and vacuum system
US11464994B2 (en) 2016-05-10 2022-10-11 Btl Medical Solutions A.S. Aesthetic method of biological structure treatment by magnetic field
US11484727B2 (en) 2016-07-01 2022-11-01 Btl Medical Solutions A.S. Aesthetic method of biological structure treatment by magnetic field
US11491342B2 (en) 2015-07-01 2022-11-08 Btl Medical Solutions A.S. Magnetic stimulation methods and devices for therapeutic treatments
US11534619B2 (en) 2016-05-10 2022-12-27 Btl Medical Solutions A.S. Aesthetic method of biological structure treatment by magnetic field
US11612758B2 (en) 2012-07-05 2023-03-28 Btl Medical Solutions A.S. Device for repetitive nerve stimulation in order to break down fat tissue means of inductive magnetic fields
US11806522B2 (en) 2020-05-05 2023-11-07 Cynosure, Llc Needle-array devices and related methods
US11806528B2 (en) 2020-05-04 2023-11-07 Btl Healthcare Technologies A.S. Device and method for unattended treatment of a patient
US11826565B2 (en) 2020-05-04 2023-11-28 Btl Healthcare Technologies A.S. Device and method for unattended treatment of a patient
US11896816B2 (en) 2021-11-03 2024-02-13 Btl Healthcare Technologies A.S. Device and method for unattended treatment of a patient

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006279865B8 (en) 2005-08-12 2013-01-31 Board Of Regents, The University Of Texas System Systems, devices, and methods for optically clearing tissue
US8048089B2 (en) 2005-12-30 2011-11-01 Edge Systems Corporation Apparatus and methods for treating the skin
US9566088B2 (en) 2006-03-29 2017-02-14 Edge Systems Llc Devices, systems and methods for treating the skin
US20090137945A1 (en) * 2007-11-28 2009-05-28 Claire Marquez Electro Collagen Induction Therapy Device
KR101836310B1 (en) 2008-01-04 2018-03-08 엣지 시스템즈 엘엘씨 Appratus and method for treating the skin
KR101013581B1 (en) 2008-08-06 2011-02-14 라종주 Electric Skin Treatment Device
US20110066162A1 (en) * 2009-09-16 2011-03-17 Vandolay, Inc. Cryo-micro-dermabrasion
NL2004558C2 (en) * 2010-04-15 2011-10-18 Lx Consult B V DEVICE FOR TREATMENT OF A TENNISELLEBOW.
DE202010013095U1 (en) * 2010-12-10 2011-02-17 Mt Derm Gmbh Device for repeated piercing of skin and lancing module
AU2011355759B2 (en) 2011-01-19 2014-09-04 Rejuvatek Medical, Llc Tattoo removal system
US9320536B2 (en) * 2011-03-03 2016-04-26 Jongju Na Method, system, and apparatus for dermatological treatment
WO2012173405A2 (en) 2011-06-14 2012-12-20 Na Jong Ju Apparatus and method for improving skin using a ra-effect or ra plus-effect
US11318009B2 (en) 2012-05-04 2022-05-03 Lipocosm, Llc Surgical tools and methods for their use
US10543127B2 (en) 2013-02-20 2020-01-28 Cytrellis Biosystems, Inc. Methods and devices for skin tightening
EP3437575B1 (en) 2013-03-15 2021-04-21 Edge Systems LLC Devices and systems for treating the skin
US10238812B2 (en) * 2013-03-15 2019-03-26 Edge Systems Llc Skin treatment systems and methods using needles
JP2016529000A (en) 2013-08-09 2016-09-23 サイトレリス バイオシステムズ,インコーポレーテッド Method and apparatus for skin treatment using non-thermal tissue ablation
US10953143B2 (en) 2013-12-19 2021-03-23 Cytrellis Biosystems, Inc. Methods and devices for manipulating subdermal fat
WO2016077759A1 (en) * 2014-11-14 2016-05-19 Cytrellis Biosystems, Inc. Devices and methods for ablation of the skin
US10179229B2 (en) 2014-12-23 2019-01-15 Edge Systems Llc Devices and methods for treating the skin using a porous member
EP3795204B1 (en) 2014-12-23 2023-10-25 HydraFacial LLC Device for treating the skin using a rollerball
RU2586278C1 (en) * 2015-01-12 2016-06-10 Александр Ливиевич Ураков Method for skin discoloration in bruising area
AU2017245174A1 (en) * 2016-03-29 2018-10-04 Cytrellis Biosystems, Inc. Devices and methods for cosmetic skin resurfacing
KR101828589B1 (en) * 2016-07-04 2018-02-13 주식회사 파나시 High-Frequency Handpiece for Skin Surgery
WO2018057630A1 (en) 2016-09-21 2018-03-29 Cytrellis Biosystems, Inc. Devices and methods for cosmetic skin resurfacing
RU2641386C1 (en) * 2016-10-24 2018-01-17 Общество с ограниченной ответственностью "Институт термологии" Method for blue nail treatment
US11504260B2 (en) 2018-10-04 2022-11-22 Lipocosm, Llc Rigidifying brace
US11540894B2 (en) 2018-10-04 2023-01-03 Lipocosm, Llc Rigiditying brace
US20210401453A1 (en) * 2018-11-07 2021-12-30 Cytrellis Biosystems, Inc. Systems and methods for skin treatment
US11793245B2 (en) 2020-12-07 2023-10-24 Lipocosm, Llc Brassiere with slidable rims
USD1016615S1 (en) 2021-09-10 2024-03-05 Hydrafacial Llc Container for a skin treatment device

Citations (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US55775A (en) * 1866-06-19 Improvement in instruments for irritating the skin
US2009562A (en) * 1932-12-23 1935-07-30 Okumura Yasujiro Stimulus acupuncturator
US3086530A (en) * 1958-12-10 1963-04-23 Allen & Hanburys Ltd Surgical multiple puncture devices
US3193908A (en) * 1963-10-03 1965-07-13 Newport News S & D Co Needle scaler
US3756242A (en) * 1972-01-04 1973-09-04 Micro Motors Inc Mechanical scarifier
US4088128A (en) * 1975-09-04 1978-05-09 Mabuchi Motor Co., Ltd. Beauty treatment device
US4204438A (en) * 1978-06-02 1980-05-27 Christopher Binaris Tattooing device
US4565189A (en) * 1981-10-08 1986-01-21 Bio Mabuchi Co. Ltd. Beauty treatment device
US5471102A (en) * 1994-05-09 1995-11-28 Becker; Gregory R. Reciprocating shaft device
US5564436A (en) * 1995-09-21 1996-10-15 Hakky; Said I. Automatic rotating cassette multiple biopsy device
US5593381A (en) * 1994-07-25 1997-01-14 Neptune Pundak & Ayalon Ltd. Skin and tissue treatment and stimulation device and method
US5647851A (en) * 1995-06-12 1997-07-15 Pokras; Norman M. Method and apparatus for vibrating an injection device
US5681283A (en) * 1995-02-27 1997-10-28 Brownfield; Carroll James Device for painless insertion of needle for needle injected medication
US5873856A (en) * 1995-06-22 1999-02-23 Pharmacia Ab Limited depth penetration needle housing
US5964729A (en) * 1994-05-23 1999-10-12 Samsung Electro-Mechanics Co., Ltd. Perforating device for dermal administration
US5968063A (en) * 1997-05-14 1999-10-19 Jennifer Chu Intramuscular stimulation therapy facilitating device and method
US5976167A (en) * 1996-05-01 1999-11-02 Lee; Young H. Intramuscular stimulator having a puncture aid
US6024706A (en) * 1996-03-26 2000-02-15 Hsiao; Ray-Ling Quantitative skin allergic test device
US6027515A (en) * 1999-03-02 2000-02-22 Sound Surgical Technologies Llc Pulsed ultrasonic device and method
US6030404A (en) * 1997-09-06 2000-02-29 Lawson; Alexis A. Skin penetration apparatus including multiple needle configuration
US6090790A (en) * 1989-12-14 2000-07-18 Eriksson; Elof Gene delivery by microneedle injection
US20020072717A1 (en) * 2000-06-26 2002-06-13 Mueller Richard L. Method and apparatus for treating ischemic tissue
US20020177839A1 (en) * 2001-04-20 2002-11-28 Cormier Michel J. N. Microprojection array having a beneficial agent containing coating
US20030069548A1 (en) * 2001-10-05 2003-04-10 Connelly Robert I. Microdevice and method of delivering of withdrawing a substance through the skin of an animal
US20040019371A1 (en) * 2001-02-08 2004-01-29 Ali Jaafar Apparatus and method for reducing subcutaneous fat deposits, virtual face lift and body sculpturing by electroporation
US6723091B2 (en) * 2000-02-22 2004-04-20 Gyrus Medical Limited Tissue resurfacing
US20040087992A1 (en) * 2002-08-09 2004-05-06 Vladimir Gartstein Microstructures for delivering a composition cutaneously to skin using rotatable structures
US20050070948A1 (en) * 2003-09-26 2005-03-31 Kirsteins Andrew E. Subcutaneous insertion devices and methods for stimulating subcutaneous regions of patients
US6890319B1 (en) * 1998-08-13 2005-05-10 Imprint Pharmaceuticals Ltd. Apparatus for delivering a substance having one or more needles driven at high velocity
US20060122453A1 (en) * 2004-12-02 2006-06-08 Nikolay Alekseyenko Therapeutic device for local area stimulation
US20060135844A1 (en) * 2004-12-02 2006-06-22 Nikolay Alekseyenko Therapeutic device for local area stimulation
US7087063B2 (en) * 2003-02-19 2006-08-08 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Abrasion device and method
US20070073217A1 (en) * 2005-07-14 2007-03-29 James Terry L Apparatus, system, and method to deliver optimal elements in order to enhance the aesthetic appearance of the skin
US20070129714A1 (en) * 2005-05-20 2007-06-07 Echo Healthcare Llc Subdermal cryogenic remodeling of muscles, nerves, connective tissue, and/or adipose tissue (FAT)
US7494488B2 (en) * 1998-05-28 2009-02-24 Pearl Technology Holdings, Llc Facial tissue strengthening and tightening device and methods

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2232331B1 (en) * 1973-06-06 1978-03-24 Guerin A Ets
US6251100B1 (en) * 1993-09-24 2001-06-26 Transmedica International, Inc. Laser assisted topical anesthetic permeation
US5549640A (en) * 1995-06-08 1996-08-27 Fontenot; Mark G. Device and method for enhancement of wound healing
JPH11511763A (en) * 1996-06-24 1999-10-12 ユーロ―セルティーク,エス.エイ. How to provide safe local anesthesia
US6256533B1 (en) * 1999-06-09 2001-07-03 The Procter & Gamble Company Apparatus and method for using an intracutaneous microneedle array
WO2003009886A2 (en) * 2001-07-25 2003-02-06 Injectimed, Inc. Method and apparatus for indicating or covering a percutaneous puncture site
US7695486B2 (en) * 2002-10-02 2010-04-13 Linda Dixon Intradermal color introducing needle device, and apparatus and method involving the same
US6960214B2 (en) * 2002-10-15 2005-11-01 Zimmer Austin, Inc. Method for performing automated microfracture
US20050203575A1 (en) * 2004-03-15 2005-09-15 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Skin microactivation system and method

Patent Citations (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US55775A (en) * 1866-06-19 Improvement in instruments for irritating the skin
US2009562A (en) * 1932-12-23 1935-07-30 Okumura Yasujiro Stimulus acupuncturator
US3086530A (en) * 1958-12-10 1963-04-23 Allen & Hanburys Ltd Surgical multiple puncture devices
US3193908A (en) * 1963-10-03 1965-07-13 Newport News S & D Co Needle scaler
US3756242A (en) * 1972-01-04 1973-09-04 Micro Motors Inc Mechanical scarifier
US4088128A (en) * 1975-09-04 1978-05-09 Mabuchi Motor Co., Ltd. Beauty treatment device
US4204438A (en) * 1978-06-02 1980-05-27 Christopher Binaris Tattooing device
US4565189A (en) * 1981-10-08 1986-01-21 Bio Mabuchi Co. Ltd. Beauty treatment device
US6090790A (en) * 1989-12-14 2000-07-18 Eriksson; Elof Gene delivery by microneedle injection
US5471102A (en) * 1994-05-09 1995-11-28 Becker; Gregory R. Reciprocating shaft device
US5964729A (en) * 1994-05-23 1999-10-12 Samsung Electro-Mechanics Co., Ltd. Perforating device for dermal administration
US5593381A (en) * 1994-07-25 1997-01-14 Neptune Pundak & Ayalon Ltd. Skin and tissue treatment and stimulation device and method
US5681283A (en) * 1995-02-27 1997-10-28 Brownfield; Carroll James Device for painless insertion of needle for needle injected medication
US5647851A (en) * 1995-06-12 1997-07-15 Pokras; Norman M. Method and apparatus for vibrating an injection device
US5873856A (en) * 1995-06-22 1999-02-23 Pharmacia Ab Limited depth penetration needle housing
US5564436A (en) * 1995-09-21 1996-10-15 Hakky; Said I. Automatic rotating cassette multiple biopsy device
US6024706A (en) * 1996-03-26 2000-02-15 Hsiao; Ray-Ling Quantitative skin allergic test device
US5976167A (en) * 1996-05-01 1999-11-02 Lee; Young H. Intramuscular stimulator having a puncture aid
US5968063A (en) * 1997-05-14 1999-10-19 Jennifer Chu Intramuscular stimulation therapy facilitating device and method
US6030404A (en) * 1997-09-06 2000-02-29 Lawson; Alexis A. Skin penetration apparatus including multiple needle configuration
US7494488B2 (en) * 1998-05-28 2009-02-24 Pearl Technology Holdings, Llc Facial tissue strengthening and tightening device and methods
US6890319B1 (en) * 1998-08-13 2005-05-10 Imprint Pharmaceuticals Ltd. Apparatus for delivering a substance having one or more needles driven at high velocity
US6027515A (en) * 1999-03-02 2000-02-22 Sound Surgical Technologies Llc Pulsed ultrasonic device and method
US6723091B2 (en) * 2000-02-22 2004-04-20 Gyrus Medical Limited Tissue resurfacing
US20020072717A1 (en) * 2000-06-26 2002-06-13 Mueller Richard L. Method and apparatus for treating ischemic tissue
US20040019371A1 (en) * 2001-02-08 2004-01-29 Ali Jaafar Apparatus and method for reducing subcutaneous fat deposits, virtual face lift and body sculpturing by electroporation
US20020177839A1 (en) * 2001-04-20 2002-11-28 Cormier Michel J. N. Microprojection array having a beneficial agent containing coating
US20030069548A1 (en) * 2001-10-05 2003-04-10 Connelly Robert I. Microdevice and method of delivering of withdrawing a substance through the skin of an animal
US20040087992A1 (en) * 2002-08-09 2004-05-06 Vladimir Gartstein Microstructures for delivering a composition cutaneously to skin using rotatable structures
US7087063B2 (en) * 2003-02-19 2006-08-08 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Abrasion device and method
US20050070948A1 (en) * 2003-09-26 2005-03-31 Kirsteins Andrew E. Subcutaneous insertion devices and methods for stimulating subcutaneous regions of patients
US20060122453A1 (en) * 2004-12-02 2006-06-08 Nikolay Alekseyenko Therapeutic device for local area stimulation
US20060135844A1 (en) * 2004-12-02 2006-06-22 Nikolay Alekseyenko Therapeutic device for local area stimulation
US20070129714A1 (en) * 2005-05-20 2007-06-07 Echo Healthcare Llc Subdermal cryogenic remodeling of muscles, nerves, connective tissue, and/or adipose tissue (FAT)
US20070073217A1 (en) * 2005-07-14 2007-03-29 James Terry L Apparatus, system, and method to deliver optimal elements in order to enhance the aesthetic appearance of the skin

Cited By (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160331440A1 (en) * 2009-07-27 2016-11-17 Novoxel Ltd. Methods and devices for tissue ablation
US10327832B2 (en) * 2009-07-27 2019-06-25 Novoxel Ltd. Methods and devices for tissue ablation
US11612758B2 (en) 2012-07-05 2023-03-28 Btl Medical Solutions A.S. Device for repetitive nerve stimulation in order to break down fat tissue means of inductive magnetic fields
US11083515B2 (en) 2013-12-18 2021-08-10 Novoxel Ltd. Methods and devices for thermal tissue vaporization and compression
US11291498B2 (en) 2013-12-18 2022-04-05 Novoxel Ltd. Methods and devices for thermal tissue vaporization and compression
US10702328B2 (en) 2013-12-18 2020-07-07 Novoxel Ltd. Devices and methods for tissue vaporization
US11253718B2 (en) 2015-07-01 2022-02-22 Btl Healthcare Technologies A.S. High power time varying magnetic field therapy
US11491342B2 (en) 2015-07-01 2022-11-08 Btl Medical Solutions A.S. Magnetic stimulation methods and devices for therapeutic treatments
US11266850B2 (en) 2015-07-01 2022-03-08 Btl Healthcare Technologies A.S. High power time varying magnetic field therapy
US11253717B2 (en) 2015-10-29 2022-02-22 Btl Healthcare Technologies A.S. Aesthetic method of biological structure treatment by magnetic field
US11464993B2 (en) 2016-05-03 2022-10-11 Btl Healthcare Technologies A.S. Device including RF source of energy and vacuum system
US11247039B2 (en) 2016-05-03 2022-02-15 Btl Healthcare Technologies A.S. Device including RF source of energy and vacuum system
US11883643B2 (en) 2016-05-03 2024-01-30 Btl Healthcare Technologies A.S. Systems and methods for treatment of a patient including RF and electrical energy
US11602629B2 (en) 2016-05-03 2023-03-14 Btl Healthcare Technologies A.S. Systems and methods for treatment of a patient including rf and electrical energy
US11691024B2 (en) 2016-05-10 2023-07-04 Btl Medical Solutions A.S. Aesthetic method of biological structure treatment by magnetic field
US11464994B2 (en) 2016-05-10 2022-10-11 Btl Medical Solutions A.S. Aesthetic method of biological structure treatment by magnetic field
US11534619B2 (en) 2016-05-10 2022-12-27 Btl Medical Solutions A.S. Aesthetic method of biological structure treatment by magnetic field
US11590356B2 (en) 2016-05-10 2023-02-28 Btl Medical Solutions A.S. Aesthetic method of biological structure treatment by magnetic field
US11458307B2 (en) 2016-05-23 2022-10-04 Btl Healthcare Technologies A.S. Systems and methods for tissue treatment
US11878162B2 (en) 2016-05-23 2024-01-23 Btl Healthcare Technologies A.S. Systems and methods for tissue treatment
US11896821B2 (en) 2016-05-23 2024-02-13 Btl Healthcare Technologies A.S. Systems and methods for tissue treatment
US11623083B2 (en) 2016-05-23 2023-04-11 Btl Healthcare Technologies A.S. Systems and methods for tissue treatment
US11185690B2 (en) 2016-05-23 2021-11-30 BTL Healthcare Technologies, a.s. Systems and methods for tissue treatment
US10220195B2 (en) 2016-06-08 2019-03-05 Eclipse Medcorp, Llc Radio frequency needling device for use with disposable needle cartridges
US9636491B1 (en) 2016-06-08 2017-05-02 Eclipse Aesthetics, LLC Disposable needle cartridges having absorbing contaminant barriers
US9629991B1 (en) 2016-06-08 2017-04-25 Eclipse Aesthetics, LLC Disposable radio frequency needle cartridges having absorbing containment barriers
US11497925B2 (en) 2016-07-01 2022-11-15 Btl Medical Solutions A.S. Aesthetic method of biological structure treatment by magnetic field
US11266852B2 (en) 2016-07-01 2022-03-08 Btl Healthcare Technologies A.S. Aesthetic method of biological structure treatment by magnetic field
US11524171B2 (en) 2016-07-01 2022-12-13 Btl Medical Solutions A.S. Aesthetic method of biological structure treatment by magnetic field
US11607556B2 (en) 2016-07-01 2023-03-21 Btl Medical Solutions A.S. Aesthetic method of biological structure treatment by magnetic field
US11628308B2 (en) 2016-07-01 2023-04-18 Btl Medical Solutions A.S. Aesthetic method of biological structure treatment by magnetic field
US11679270B2 (en) 2016-07-01 2023-06-20 Btl Medical Solutions A.S. Aesthetic method of biological structure treatment by magnetic field
US11484727B2 (en) 2016-07-01 2022-11-01 Btl Medical Solutions A.S. Aesthetic method of biological structure treatment by magnetic field
US11794029B2 (en) 2016-07-01 2023-10-24 Btl Medical Solutions A.S. Aesthetic method of biological structure treatment by magnetic field
US11896299B2 (en) 2016-08-16 2024-02-13 Btl Healthcare Technologies A.S. Modular treatment device
US11141219B1 (en) 2016-08-16 2021-10-12 BTL Healthcare Technologies, a.s. Self-operating belt
US11484725B2 (en) 2019-04-11 2022-11-01 Btl Medical Solutions A.S. Methods and devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy
US11247063B2 (en) 2019-04-11 2022-02-15 Btl Healthcare Technologies A.S. Methods and devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy
US11806528B2 (en) 2020-05-04 2023-11-07 Btl Healthcare Technologies A.S. Device and method for unattended treatment of a patient
US11813451B2 (en) 2020-05-04 2023-11-14 Btl Healthcare Technologies A.S. Device and method for unattended treatment of a patient
US11826565B2 (en) 2020-05-04 2023-11-28 Btl Healthcare Technologies A.S. Device and method for unattended treatment of a patient
US11878167B2 (en) 2020-05-04 2024-01-23 Btl Healthcare Technologies A.S. Device and method for unattended treatment of a patient
US11806522B2 (en) 2020-05-05 2023-11-07 Cynosure, Llc Needle-array devices and related methods
US11896816B2 (en) 2021-11-03 2024-02-13 Btl Healthcare Technologies A.S. Device and method for unattended treatment of a patient

Also Published As

Publication number Publication date
CA2568482C (en) 2011-02-15
US7618429B2 (en) 2009-11-17
CA2568482A1 (en) 2007-06-22
US20070149991A1 (en) 2007-06-28

Similar Documents

Publication Publication Date Title
US7618429B2 (en) Skin rejuvination resurfacing method
US10799285B2 (en) Skin rejuvenation resurfacing device and method of use
US11712560B2 (en) Cosmetic skin rejuvenation
US6808532B2 (en) Laser treatment for reducing wrinkles
US9144463B2 (en) Treatment of cellulite and adipose tissue with mid-infrared radiation
JP5116488B2 (en) Skin treatment device
US20090112205A1 (en) Cartridge electrode device
DK2667801T3 (en) Method and device for discontinuous dermabrasion
US20080312647A1 (en) Methods and devices for treating tissue
Campolmi et al. Highlights of Thirty-Year Experience of C O 2 Laser Use at the Florence (Italy) Department of Dermatology
US6702838B1 (en) Method of treating hypotrophic scars enlarged pores
EP3782571B1 (en) Laser system for multiple beam tissue therapy
Munavalli et al. Photoaging and nonablative photorejuvenation in ethnic skin
Fritz et al. Ways of noninvasive facial skin tightening and fat reduction
David et al. Fast healing after laser skin resurfacing: the minimal mechanical trauma technique
Pavlidis et al. Therapeutic approaches to reducing atrophic acne scarring
CA2688510A1 (en) Skin rejuvination resurfacing device and method of use
Rostan Laser treatment of photodamaged skin
KR20230133840A (en) A cosmetic laser device that performs treatment by irradiating a variable pulse laser beam onto the human skin being treated.
Meduri Facial resurfacing: an overview
Alster Plasma Skin Rejuvenation of the Hands
WO2008157400A1 (en) Methods and devices for treating tissue
Kim Chemical Peels and Other Rejuvenation Methods for the Face
Rizk Laser Pointers

Legal Events

Date Code Title Description
AS Assignment

Owner name: SPAMEDICA INTERNATIONAL SRL, BARBADOS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MULHOLLAND, R. STEPHEN;REEL/FRAME:023205/0305

Effective date: 20090909

AS Assignment

Owner name: INVASIX LTD., ISRAEL

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SPAMEDICA INTERNATIONAL SRL;REEL/FRAME:023915/0776

Effective date: 20100210

Owner name: INVASIX LTD.,ISRAEL

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SPAMEDICA INTERNATIONAL SRL;REEL/FRAME:023915/0776

Effective date: 20100210

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION